Graft Versus Host Disease clinical trials at UCSD
3 in progress, 1 open to eligible people
Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
open to eligible people ages 12 years and up
This study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
La Jolla, California and other locations
PCI-32765 (Ibrutinib)
Sorry, in progress, not accepting new patients
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.
La Jolla, California and other locations
Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Sorry, in progress, not accepting new patients
Multicenter, open-label, prospective treatment protocol that provides continued access to ibrutinib to subjects who have completed parent ibrutinib studies, are still benefitting from treatment with ibrutinib, and have no access to commercial ibrutinib for their underlying disease within their region.
La Jolla, California and other locations
Last updated: